🩺 medi
🏠 Home 🧪 Calculators 🇰🇷 한국어 🚀 idomoa next

🧪 MoM Calculator (Prenatal Screening)

Calculate Multiple of the Median (MoM) for serum and ultrasound markers used in first- and second-trimester aneuploidy and NTD screening.

⚠️ Prenatal Screening Disclaimer
Prenatal screening results must be interpreted by a qualified obstetrician or maternal-fetal medicine specialist. This tool is for reference only; it does not compute individualized risk. Individualized risk requires validated software (PRISCA, FMF, Lifecycle) incorporating maternal age, weight, ethnicity, diabetes status, smoking, IVF, and multiple fetal number. Do not make clinical decisions from a single MoM value.
Supported: 10–22 weeks

Reference Medians by Gestational Age

Representative literature-based medians. Real medians vary by laboratory and population.

GAPAPP-A
(mIU/mL)
free β-hCG
(ng/mL)
AFP
(ng/mL)
NT
(mm)
10 wk1.245
11 wk1.8401.2
12 wk2.6351.4
13 wk3.8301.6
15 wk25
16 wk30
17 wk35
18 wk42

Classic MoM Patterns

Trisomy 21 (Down syndrome) pattern
PAPP-A · free β-hCG · AFP · uE3 · inhibin A · NT
Trisomy 18 (Edwards syndrome) pattern
PAPP-A · free β-hCG · AFP · uE3 · NT
Open neural tube defect (NTD)
AFP ↑↑ (MoM ≥ 2.5)

※ No single marker is diagnostic. Risk software combines all markers with maternal factors for individualized risk.

MoM Reference Ranges

MoM RangeCategoryInterpretation
< 0.4Very LowSignificantly low — further evaluation warranted
0.4 – 0.5LowBorderline; interpret with other markers
0.5 – 2.0NormalTypical range for most pregnancies
2.0 – 2.5HighBorderline; interpret with other markers
> 2.5Very HighSignificantly high — further evaluation warranted

Related Calculators

🩸 Preeclampsia Risk 🧬 AMH 🫀 Blood Pressure 🩺 eGFR
Disclaimer — Educational reference only. Individualized aneuploidy risk requires validated software (PRISCA, FMF, Lifecycle) with adjustment for maternal age, weight, ethnicity, smoking, diabetes, IVF, and multifetal gestation. Reference medians vary significantly by laboratory. Do not clinical decisions from single-marker MoM.
References: Wald NJ et al. J Med Screen. 1997. · Malone FD et al. FASTER Trial. NEJM. 2005. · Fetal Medicine Foundation (FMF) First-Trimester Screening Guidelines 2023.